UroGen Pharma (URGN) PT Lowered to $34 at Oppenheimer
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Price: $48.12 -1.8%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on UroGen Pharma (NASDAQ: URGN) to $34.00 (from $40.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
